ArticleAnti-cancer drugs2019

Long-term efficacy of afatinib in a patient with squamous cell carcinoma of the lung and multiple ERBB family aberrations: afatinib in ERBB+ lung squamous cell carcinoma.

Hong Jian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.